Investor & Analyst meeting and conference call:
Angus Russell, Chief Executive Officer, Graham Hetherington, Chief Financial Officer, Mike Cola, President, Specialty Pharmaceuticals and Sylvie Grégoire, President, Human Genetic Therapies hosted the investor and analyst meeting and conference call at 14:30 BST/9:30 EDT.
Replay of the audio webcast.
Slide presentation to accompany the call
Q2 Press Release